Revatio and Sjogren syndrome - a phase IV clinical study of FDA data

Summary:

Sjogren syndrome is reported as a side effect among people who take Revatio (sildenafil citrate), especially for people who are female, 60+ old, also take Tyvaso, and have Constipation.

The phase IV clinical study analyzes which people have Sjogren syndrome when taking Revatio. It is created by eHealthMe based on reports of 44,758 people who have side effects when taking Revatio from the FDA, and is updated regularly.

What is Revatio?

Revatio has active ingredients of sildenafil citrate. It is often used in pulmonary hypertension. eHealthMe is studying from 44,849 Revatio users. Check the latest studies of Revatio.

What is Sjogren syndrome?

Sjogren syndrome (a disease that causes dryness in the mouth and eyes) is found to be associated with 615 drugs and 965 conditions by eHealthMe. Check the latest studies of Sjogren syndrome.

On Jul, 08, 2026

44,758 people reported to have side effects when taking Revatio.
Among them, 12 people (0.03%) have Sjogren syndrome.

Among these 12 people:

What is the gender of people who have Sjogren syndrome when taking Revatio? *

female: 100 %
male: 0.0 %

What is the age of people who have Sjogren syndrome when taking Revatio? *

What are other drugs people take besides Revatio? *

What are other side effects people have besides Sjogren syndrome? *

Dyspnea (difficult or laboured breathing): 5 people, 41.67%
Dry Mouth: 4 people, 33.33%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 25.00%
Chest Pain: 3 people, 25.00%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 3 people, 25.00%
Swelling: 3 people, 25.00%
Oral Herpes (viral infection of mouth): 3 people, 25.00%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Diarrhea: 2 people, 16.67%

What are the existing conditions these people have? *

Asthma: 2 people, 16.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 16.67%
Neuropathy Peripheral (surface nerve damage): 2 people, 16.67%
Itching: 2 people, 16.67%
Cardiac Failure: 2 people, 16.67%
Herpes Zoster: 2 people, 16.67%
Constipation: 2 people, 16.67%
Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 1 person, 8.33%
Blood Magnesium Decreased: 1 person, 8.33%
Blood Potassium Decreased: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Revatio and have Sjogren syndrome?

- Check whether Sjogren syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Revatio:

Revatio (44,849 reports)

Sjogren syndrome treatments and more:

Sjogren syndrome (12,488 reports)

Browse all side effects of Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sjogren syndrome:

Sjogren syndrome (615 drugs)

Browse all the conditions that are associated with Sjogren syndrome:

Sjogren syndrome (965 conditions)

Related publications that referenced our studies

Jeong SY, Jeon SJ, Kim YR, Choi SS, Kwak HS, "A Rare Case of Viagra Induced Toxic Encephalopathy", Investigative Magnetic Resonance Imaging, 2016 Sep .
Jeong SY, Jeon SJ, Kim YR, Choi SS, Kwak HS, "A Rare Case of Viagra Induced Toxic Encephalopathy", Investigative Magnetic Resonance Imaging, 2016 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on sildenafil citrate (the active ingredients of Revatio) and Revatio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.